If you’ve found yourself unexpectedly humming the tune “Magic” lately, you’re not alone. Thanks to the catchy commercial for ...

French researchers have developed a new drug delivery system that could cut the dosing schedule for type 2 diabetes and ...

They were a bellwether.” All three have changed their shopping habits after slimming down on glucagon-like peptide-1, or ...

In this article, we take a look at six biotech companies focused on bringing drugs to treat obesity to the market.

Semaglutide, a GLP-1 analog, may influence lipid metabolism and adipose tissue regulation by interacting with adipocytes, ...

GLP-1 agonists may improve the disease course for a host of neurological and psychiatric disorders tied to inflammation, ...

Eli Lilly, the makers of tirzepatide—which they sell as Mounjaro for diabetes and Zepbound for weight loss— announced ...

In people with diabetes, the "oatzempic" online diet fad may lead to increased glucose, decreased muscle mass, and ...

A research group led by Prof. Zhu Yingjie from the Shenzhen Institute of Advanced Technology (SIAT) of the Chinese Academy of ...

A Pennsylvania mom is suing the maker of Ozempic and Wegovy claiming she nearly died from taking the prescription drugs and ...